Skip to main content
. 2017 Jan 11;12:233–242. doi: 10.2147/COPD.S119467

Table 1.

Sociodemographic, lifestyle, clinical, and occupational characteristics of COPD patients of working age recruited to the Birmingham COPD Cohort Study

Participant characteristics Male, number (%);
n=343
Female, number (%);
n=265
Total number (%);
n=608
Sociodemographic characteristics
Age categories (years)
 38–49 40 (11.7) 28 (10.6) 68 (11.2)
 50–59 125 (36.4) 128 (48.3) 253 (41.6)
 60–64 178 (51.9) 109 (41.1) 287 (47.2)
Education level
 Degree or higher level 33 (12.1) 25 (12.0) 58 (12.0)
 A level/AS level or equivalent 21 (7.7) 15 (7.2) 36 (7.5)
 GCSE, CSE, O level, or equivalent 73 (26.7) 67 (32.1) 140 (29.1)
 No formal qualification 146 (53.5) 102 (48.8) 248 (51.5)
IMD score quintiles
12345increasing deprivation 110 (32.4) 74 (27.9) 184 (30.4)
70 (20.6) 66 (24.9) 136 (22.5)
160 (47.1) 125 (47.2) 285 (47.1)
Lifestyle characteristics
 Smoking status
 Never smoked 23 (7.2) 19 (7.9) 42 (7.5)
 Ex-smoker 135 (42.5) 104 (43.2) 239 (42.8)
 Current smoker 160 (50.3) 118 (49.0) 278 (49.7)
Clinical characteristics
MRC dyspnea grade
12345Increasing breathlessness 81 (24.8) 44 (17.2) 125 (21.4)
57 (17.4) 46 (18.0) 103 (17.8)
68 (20.8) 62 (24.2) 130 (22.3)
121 (37.0) 104 (40.6) 225 (38.6)
CAT score
Low(high QOL)MediumHighVery high(poor QOL)Increasing symptom impact 40 (15.1) 26 (12.5) 66 (14.0)
102 (38.5) 72 (34.6) 174 (36.8)
87 (32.8) 79 (38.0) 166 (35.1)
36 (13.6) 31 (14.9) 67 (14.2)
Degree of airflow obstruction (GOLD stage)a,b
 Mild 91 (28.0) 84 (32.9) 175 (30.2)
 Moderate 154 (47.4) 133 (52.2) 287 (49.5)
 Severe to very severe 80 (24.6) 38 (14.9) 118 (20.3)
Exacerbations in the last 12 months
 0 146 (47.7) 82 (33.7) 228 (41.5)
 1–2 110 (36.0) 92 (37.9) 202 (36.8)
 3+ 50 (16.3) 69 (28.4) 119 (21.7)
Modified BODE index score quartilesa
1234Increasing severity 103 (41.2) 82 (39.1) 185 (40.2)
72 (28.8) 57 (27.1) 129 (28.0)
46 (18.4) 49 (23.3) 95 (20.7)
29 (11.6) 22 (10.5) 51 (11.1)
Number of comorbidities
 0 64 (18.7) 25 (9.4) 89 (14.6)
 1–2 140 (40.8) 110 (41.5) 250 (41.1)
 3+ 139 (40.5) 130 (49.1) 269 (44.2)
Comorbidities
 Cardiovascular disease 155 (51.0) 113 (46.9) 268 (49.2)
 Depression 86 (28.1) 95 (38.8) 181 (32.9)
 Gastrointestinal disease 89 (27.2) 71 (28.4) 160 (27.7)
 Osteoarthritis 42 (14.4) 47 (19.8) 89 (16.8)
 Diabetes 46 (15.3) 27 (11.2) 73 (13.5)
 Rheumatoid arthritis 29 (10.0) 37 (15.5) 66 (12.5)
 Cancer 18 (6.0) 25 (10.3) 43 (7.9)
BMI categories
 Underweight (<18.5) 8 (2.5) 8 (3.1) 16 (2.8)
 Normal (18.5–24.9) 83 (25.5) 73 (28.4) 156 (26.8)
 Overweight (25–29) 132 (40.6) 73 (28.4) 205 (35.2)
 Obese (30–39.0) 96 (29.5) 76 (29.6) 172 (29.6)
 Severe obesity (≥40.0) 6 (1.9) 27 (10.5) 33 (5.7)
Mean sit-to-stand repetitions (SD) 20.8 (6.6) 19.8 (6.6) 20.4 (6.6)
Occupational characteristics
Occupational background (SOC 2010)
 Managers, directors, and senior officials 20 (5.9) 17 (6.6) 37 (6.2)
 Professional 27 (8.0) 28 (10.9) 55 (9.2)
 Associate professional and technical 28 (8.3) 11 (4.3) 39 (6.5)
 Administrative and secretarial 5 (1.5) 48 (18.7) 53 (8.9)
 Skilled trade 116 (34.2) 12 (4.7) 128 (21.5)
 Caring, leisure, and other services 7 (2.1) 38 (14.8) 45 (7.6)
 Sales and customer service 7 (2.1) 21 (8.2) 28 (4.7)
 Process, plant, and machine operatives 87 (25.7) 39 (15.2) 126 (21.1)
 Elementary 42 (12.4) 43 (16.7) 85 (14.3)
Exposures to VGDF in longest held job
NoneLowMidiumHighIncreasing occupational airborne exposure 65 (19.2) 129 (50.4) 194 (32.6)
129 (38.1) 73 (28.5) 202 (34.0)
78 (23.0) 49 (19.1) 127 (21.3)
67 (19.8) 5 (2.0) 72 (12.1)

Notes:

a

Airflow obstruction based on postbronchodilator FEV1 % predicted (mild: FEV1 ≥80% predicted; moderate: 50% ≤ FEV1 <80% predicted; severe: 30% ≤ FEV1 <50% predicted, and very severe: FEV1 <30% predicted);

b

Includes 94 participants (male: n=38 and female: n=56) who did not have airflow obstruction on the day of assessment. Total numbers may differ due to some missing data.

Abbreviations: BMI, body mass index; BODE, body mass index, airflow obstruction, dyspnea, and exercise; CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; GOLD, Global Initiative for Chronic Obstructive Lung Disease; IMD, index of multiple deprivation; MRC, Medical Research Council; QOL, quality of life; SD, standard deviation; SOC, standard occupational classification; VGDF, vapors, gases, dusts, or fumes.